HIV i-Base
@hiv-i-base
HIV treatment activist charity founded in 2000, working in the UK and internationally to improve quality of care for HIV positive people. #HIVsky #ResearchSky #IDsky Website:
Activists challenge US Government over “shameful” #PEPFAR cuts: i-base.info/htb/54322 @asia-ilse.bsky.social & others disrupted a session by the US government to demand an end to their ‘America First Global Health Strategy’. #HIV #AIDS2026 @aidsconference.bsky.social @housingworksnyc.bsky.social
High efficacy continues in open-label extensions to #lenacapavir phase 3 #PrEP studies: i-base.info/htb/54286 Adherence and uptake of the 6-monthly injections was high. One new #HIV transmission in PURPOSE 2 raises questions, but with few details until Thursday. #AIDS20206 #HIVsky #HIVprevention
#RethinkRebuildRise at #AIDS2026: Our highlights of a diverse and exciting programme: i-base.info/aids-2026-pr... Including new drugs in the #HIV pipeline, #HIVcure research, #PrEP, the #HIVFundingCrisis, #TransgenderHealth and more. #HIVsky #HIVresearch #IDsky @aidsconference.bsky.social
#CROI2026: Low levels of #bNAbs detected in rectal tissue up to 46 weeks post infusion: i-base.info/htb/53923 Researchers say this shows the importance of including tissue sampling in cure-related #bNAb studies. #HIVsky #IDsky #HIV #HIVcure #HIVresearch #HIVtreatment #HIVscience
New guidelines on persistent low-level #ViralLoad in people living with #HIV published in The Lancet HIV: i-base.info/htb/54062 #HIVsky #IDsky #HIVguidelines #HIVtreatment #HIVpositive #viraemia #viremia #LowLevelViraemia #LowLevelViremia #ViralLoadTesting #ResistanceTesting #Adherence #PLWH
Once-weekly oral islatravir/lenacapavir meets 48-week primary endpoint in phase 3 studies: i-base.info/htb/54057 #ISLEND study results bring a #LongActing #OralART option closer to people living with #HIV. #HIVsky #HIVtreatment #HIVpositive #islatravir #lenacapavir #WeeklyART #HIVresearch
#Transgender health in #Australia – #HIV drops by 94% as #PrEP increases over 10 years: i-base.info/htb/53800 This large study in @thelancet.com shows the importance of collecting accurate data to support #TransgenderHealth. #HIVsky #IDsky #GUMsky #HIVprevention @dentoncallander.bsky.social
#BHIVABASHH26: Limited #DrugResistance after #doxyPEP introduced in Liverpool: i-base.info/htb/53891 #HIVsky #IDsky #GUMsky #BHIVABASHH2026 #InfectiousDiseases #SexualHealth #STI #syphilis #chlamydia #gonorrhoea #gonorrhea #AntibioticResistance @bhiva.bsky.social @bashhuk.bsky.social
Clinton Health Access Initiative reports impact of #HIV funding cuts. Reduced CD4 and viral load testing, #PrEP and ART initiations – children fare worst: i-base.info/htb/54042 Plus #injectable #lenacapavir #PrEP now available in #SouthAfrica. #HIVsky #HIVFundingCrisis #GlobalAid #SaveHIVfunding
#UKHSA continues to recommend #4CMenB vaccine against gonorrhoea in gay men: i-base.info/htb/54048 It cites the #JCVI’s advice, despite growing evidence of little to no effect of the vaccine to prevent #gonorrhoea. #IDsky #GUMsky #GoGoVax #DOXYVAC #MenGO #SexualHealth #STI #GBMSM #gonorrhea
#BHIVABASHH26: Liverpool University launches new #PrEP drug interaction website: i-base.info/htb/53854 With the ability to check over 1100 compounds, this new website is instantly an essential global resource. #BHIVABASHH2026 #HIVsky #HIVprevention @bhiva.bsky.social @liverpoolddis.bsky.social
#Chemsex data, service needs and how health workers can help: i-base.info/htb/54000 Rough estimates say 30% of GBMSM + trans people have used chemsex. Are support services meeting their needs? #BHIVABASHH2026 #HIV #HIVpositive #PLWH #HIVsky #IDsky #GUMsky @bhiva.bsky.social @bashhuk.bsky.social
First reports from the @bhiva.bsky.social/ @bashhuk.bsky.social Joint Conference 2026: i-base.info/htb/53878 On #neurodivergence and #adherence, #PrEP interactions, #doxyPEP and the latest data on engagement with #SexualHealthClinics. #BHIVABASHH26 #HIV #HIVprevention #Autism #ADHD #HIVsky #GUMsky
New study predicts that #PrEP efficacy in men is driven by drug levels in immune cells: i-base.info/htb/53928 This matches earlier results in women and disproves the idea that drug levels in genital tissue are the key to protection. #HIV #HIVprevention #PrEPforWomen #HIVsky #IDsky #GUMsky
Report on England’s #HIV Action Plan: i-base.info/htb/53945 England is on target to meet the 2030 goal on preventable deaths but not for diagnoses. The plan also misses some #UNAIDS key populations. #HIVsky #HIVtargets #HIVtesting #HIVprevention #PrEP #HIVstigma #SexWorkers @bhiva.bsky.social
We offer solidarity with our trans followers this #TransgenderDayOfVisibility as we revisit last year’s Lancet #HIV article: #Transgender people accessing #hormones are more likely to stay #undetectable and less likely to become #HIVpositive. i-base.info/htb/50802 #GAHT #HIVsky #GUMsky #TDOV
Pritelivir active against drug-resistant #herpes in phase 3 study: i-base.info/htb/53453 The US FDA has given #pritelivir Breakthrough Indication designation, with submission of a New Drug Indication expected by the end of March. #CROI2026 #HIV #HSV #CureHerpes #IDsky #HIVsky #GUMsky
Two cases of severe #hyperglycemia with injectable CAB/RPV-LA: i-base.info/htb/53413 Though not listed as an adverse event, paper authors advise that anyone with a high BMI or even mildly increased #glycemia may need close monitoring. #HIV #HIVsky #EndoSky #MedSky #HIVtreatment #Cabenuva #Diabetes
Assaults continue on #LGBTQI people in #Uganda. @hrapfuganda.bsky.social’s report has the latest cases, including violent attacks or threats, evictions, police entrapment, extortion & discrimination in healthcare settings. Examples here – these may be distressing: i-base.info/htb/53403 #AHA23
Study of #4CMenB #vaccine in #Australia fails to protect gay men against #gonorrhoea: i-base.info/htb/53465 Will other study results be more positive or do we need a better vaccine? #CROI2026 #GUMsky #IDsky #STI #SexualHealth #gonorrhea #GonorrhoeaVaccine #LoveGUM #STIprevention #STIawareness
New paper in @bmj.com shows GLP-1 receptor agonists can tackle #SubstanceUseDisorder: i-base.info/htb/53421 Could they also help to break #chemsex addiction? #HIVsky #GUMsky #HIV #PLWH #PWH #HIVpositive #GLP1s #GLP1ReceptorAgonists #Ozempic #Wegovy #Mounjaro #semaglutide #tirzepatide #addiction
US #HIV activist @peterstaley.bsky.social opens #CROI2026, saying we must all be activists until the next US administration: i-base.info/htb/53352 He offers much-needed encouragement to look to the lessons of the past as we rebuild for the future. Watch his speech via our link. #SaveHIVfunding
Once-daily oral BIC/LEN in ARTISTRY studies simplifies #HIVtreatment for those on complex combinations: i-base.info/htb/53317 Reducing the pill burden for people on several tablets a day due to #DrugResistance will improve quality of life. #CROI2026 #HIV #HIVsky #Gilead #bictegravir #lenacapavir
Final results from #PREVENIR at #CROI2026 show continued #HIV protection from 2:1:1 #PrEP dosing in gay and bisexual men in #Paris: i-base.info/htb/53282 The study also highlights the need for better #PrEPaccess in #France for those born abroad. #HIVsky #HIVprevention #HIVresearch #SexualHealth
US funding cuts set to cause 23 million excess deaths in the poorest countries by 2030: i-base.info/htb/53179 New @lancetgh.bsky.social paper predicts that 5.4 million of these will be children under 5. #HIVsky #IDsky #GlobalHealth #GlobalAid #HIV #InfantMortality #malaria #LMICs #USAID #PEPFAR
Cancer and #WomenLivingWithHIV: results from D:A:D and RESPOND support #cancer screening in routine #HIVcare: i-base.info/htb/53082 This large longitudinal study also identifies cancer risk factors. #HIV #HIVsky #HIVpositive #HIVwomen #HIVtreatment #BreastCancer #LungCancer #HPV #Europe #PLWH
Event-based #PrEP dosing for women: a challenge to #guidelines and an activist issue: i-base.info/htb/52959 Two new papers in @jidjournal.bsky.social offer the hope of simpler event-based dosing using only 4-5 pills. #HIVsky #HIVprevention #PrEP4women #HIV #PrEPguidelines #HIVguidelines
Confirmed safety of #KidneyTransplant when the recipient is and donor was #HIVpositive: i-base.info/htb/53077 #HOPEinAction study findings enable much shorter waiting lists for people with #HIV. #HIVsky #PLWH #HIVtransplant #transplant #HOPEtransplants #HOPEact @jhu.edu @cidjournal.bsky.social
88% of the diverse cohort achieved viral suppression at 12 weeks – up from 55%, with 98% of tests showing a positive result for #tenofovir (ART): i-base.info/htb/53065 Results support more research into #ContingencyManagement in #HIVcare #HIV #HIVsky #adherence #StimulantUseDisorder #HIVtreatment